Enzymes, Ion Channels, and Regulatory Proteins

The term Enzymes, Ion Channels, and Regulatory Proteins refers to a broad classification of biological molecules that serve as the primary targets for the majority of pharmaceutical agents. Enzymes are biological catalysts that facilitate chemical reactions, and their inhibition or activation is a cornerstone of treating metabolic, infectious, and inflammatory diseases (Source: Rang & Dale's Pharmacology). Ion channels are membrane proteins that control the flow of ions, such as sodium, potassium, and calcium, across cell membranes, making them vital targets for treating cardiac, neurological, and muscular disorders (Source: Nature Reviews Drug Discovery). Regulatory proteins include a wide variety of molecules, such as transcription factors and signaling proteins, that govern cellular growth, differentiation, and homeostasis (Source: UniProt). Because this entry represents a high-level grouping of diverse protein families rather than a specific, individual molecular target, it cannot be assigned a single canonical sequence or a specific set of clinical biomarkers. In drug development, these categories are used to define the druggable genome and organize research efforts based on the structural and functional properties of the proteins involved.

Other names

Drug target classesTherapeutic protein familiesMajor classes of drug targets

Various mechanisms including competitive and non-competitive inhibition, allosteric modulation, pore blocking, and stabilization of protein-protein interactions.